4mon
GlobalData on MSNBiogen and Neomorph enter molecular glue degrader dealBiogen and Neomorph have entered a research partnership aimed at discovering and developing molecular glue degraders for the ...
Hosted on MSN1mon
AbbVie and Neomorph link on oncology/immunology glue degradersAbbVie and Neomorph are forming a partnership and option-to-license agreement to develop molecular glue degraders, aiming to introduce a new class of treatments across oncology and immunology.
Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platform Neomorph to receive an upfront payment and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results